logo
15:42 Dec 05

Beta Drugs Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
1632.20
-39.20 (-2.35%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Beta Drugs Ltd. Financials

Beta Drugs Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
1632.20
-39.20 (-2.35%)
15:42 Dec 05
Quality
image/svg+xml

0/100
Not Eligible

Valuation
image/svg+xml

20/100
Expensive Valuation

Technical

40/100
Technically Neutral

Strength

5

Weakness

7

Opportunity

1

Threats

0

21.52 %

ROE %

9.72 %

ROA %

0.00

EPS

195.25

BVPS

11.70 %

Net Profit Margin

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales
116.12 183.84 227.11 295.71 362.36
Operating Expenses +
91.38 141.14 173.99 235.72 287.75
Raw Material
60.55 96.21 110.4 167.65 175.78
Increase Decrease in Cost
-1.77 -1.75 -4.71 -18.24 -4.42
Other Manufacturing Expense
13.4 17.78 24.29 31.79 0
Employee Cost
10.88 15.91 22.7 25.89 33.97
Miscellaneous Expenses
8.32 12.99 21.31 28.63 82.42
Operating Profit
24.74 42.7 53.12 59.99 74.61
Other Income
0.5 0.76 0.75 1.36 6.44
Depreciation
6.87 7.25 10.41 9.78 12.51
Interest
2.42 1.9 2.41 2.82 6.99
Profit before tax and exceptio..
15.95 34.3 41.06 48.75 61.54
Exceptional Items
0 0 0 0 -4.57
PBT
15.95 34.3 41.06 48.75 56.97
Provision for Taxation
4.23 9.47 10.34 12.32 14.55
Net Profit
11.72 24.83 30.72 36.44 42.42
NET Profit after MI
11.72 24.83 30.72 36.44 42.42
EPS
12.2 25.82 31.95 37.9 42.02
Operating Profit Margin (%)
21.31 23.23 23.39 20.29 20.59
Net Profit Margin (%)
10.09 13.51 13.53 12.32 11.71

Beta Drugs Ltd. Shareholding

Promoter

FII

Public

All Data in Percentage (%)

Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025
Promoter 66.70 66.70 66.70 66.70 66.70 66.70
FII 0.90 0.90 0.90 1.20 1.20 0.90
Public 0.30 0.30 0.20 0.10 0.10 0.10
Others 32.10 32.10 32.20 32.00 32.00 32.30
Shareholder Shares Holding %
Research 360 logo
Download Our App On: